About AVT
Browse Articles
Authors
Customer Services

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please note that the journal is running later than expected due to COVID-19.

During the transition, you can still access content to which you have subscribed via the AVT website. Content will be available to access via the SAGE Journals platform in Summer 2021. https://uk.sagepub.com/en-gb/eur/antiviraltherapy.

If you have any questions relating to the transfer, please contact journaltransitions@sagepub.com

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Subscriptions Please note that Antiviral Therapy is running later than expected due to COVID-19.

All subscription queries should be sent to subscriptions@sagepub.co.uk

Orders via subscription agents
If you are using a subscription agent, please instruct your agent as usual. We are notifying all subscription agents of this change of publisher and they will be able to handle your query.

Pricing enquiries 2021 Antiviral Therapy pricing set by International Medical Press will be honoured.

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please continue to submit your manuscripts to the AVT ScholarOne site (https://mc.manuscriptcentral.com/avt)

For papers already in peer-review, you will be informed of a decision as soon as possible. All accepted papers not assigned to a 2020 issue will now be published by SAGE.

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 24 Issue 7 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2311 results:

Free
Short communication

Statin effect on coronary calcium distribution, mass and volume scores and associations with immune activation among HIV+ persons on antiretroviral therapy

Jerry Lipinski, Seunghee Margevicius, Mark D Schluchter, David L Wilson, Grace A McComsey, Chris T Longenecker

Antiviral Therapy 2020; 25:419-424


Free
Original article

Effect of vitamin D3 and calcium carbonate supplementation on muscle strength in postmenopausal women living with HIV

Michael T Yin, Mariana Bucovsky, John Williams, Danielle Brunjes, Arindam RoyChoudhury, Ivelisse Colon, David C Ferris, Susan Olender, P Christian Schulze, Anjali Sharma, Cosmina Zeana, Barry Zingman, Elizabeth Shane

Antiviral Therapy 2020; 25:411-418


Free
Original article

Antiviral activity of 1,4-disubstituted-1,2,3-triazoles against HSV-1 in vitro

Daiane J Viegas, Verônica D da Silva, Camilla D Buarque, David C Bloom, Paula A Abreu

Antiviral Therapy 2020; 25:399-410


Free
Review

COVID-19 and hepatitis B infection

Saleh A Alqahtani, Maria Buti

Antiviral Therapy 2020; 25:389-397


Free
Original article

Treatment modification after second-line failure among people living with HIV in Asia-Pacific

Awachana Jiamsakul, Iskandar Azwa, Fujie Zhang, Evy Yunihastuti, Rossana Ditangco, Nagalingeswaran Kumarasamy, Oon Tek Ng, Yu-Jiun Chan, Penh Sun Ly, Jun Yong Choi, Man-Po Lee, Sanjay Pujari, Sasisopin Kiertiburanakul, Romanee Chaiwarith, Tuti Parwati Merati, Shashikala Sangle, Suwimon Khusuwan, Benedict LH Sim, Anchalee Avihingsanon, Cuong Duy Do, Junko Tanuma, Jeremy Ross, Matthew Law, the TREAT Asia HIV Observational Database of IeDEA Asia-Pacific

Antiviral Therapy 2020; 25:377-387


Free
Original article

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review

Jienchi Dorward, Oghenekome Gbinigie, Ting Cai, Nia W Roberts, Nigel Garrett, Gail Hayward, Christopher C Butler

Antiviral Therapy 2020; 25:365-376


Free
Original article

Antiviral activity of different extracts of standardized propolis preparations against HSV

Sevda Demir, Ali Timucin Atayoglu, Fabio Galeotti, Emanuele U Garzarella, Vincenzo Zaccaria, Nicola Volpi, Ali Karagoz, Fikrettin Sahin

Antiviral Therapy 2020; 25:353-363


Free
Commentary

How can the latent cytomegalovirus cause an increase in all-cause mortality? An answer based on the microcompetition model

Hanan Polansky

Antiviral Therapy 2020; 25:349-351


Free
Commentary

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Elise J Smolders, Lindsey HM te Brake, David M Burger

Antiviral Therapy 2020; 25:345-347


Free
Case report

Cytomegalovirus infection associated with severe intraocular inflammation in an HIV patient: a case report

Viviana P Lezcano Carduz, Nicolás Alejandre Alba, Elena Guzmán Almagro, Olga Sánchez Pernaute

Antiviral Therapy 2020; 25:341-344


Page:
Copyright © 2021 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.